# Cleara Biotech

founded in 2018, develops the FOXO4-DRI senolytic peptide, which disrupts the FOXO4-p53 interaction to selectively trigger apoptosis in senescent cells.

Source: https://en.bioecon.ru/companies/cleara-biotech/
Updated: 2026-07-03

- Country: Netherlands

## Technologies

- [Geroscience & senolytics](https://en.bioecon.ru/technology/geroscience-senolytics/)